Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective

[1]  J. Cameron,et al.  Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma , 2017, Annals of surgery.

[2]  I. B. Borel Rinkes,et al.  Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  Gang Chen,et al.  Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases , 2016, OncoTargets and therapy.

[4]  Ping Wang,et al.  Oncotargets and Therapy Dovepress Stereotactic Body Radiation Therapy for Patients with Recurrent Pancreatic Adenocarcinoma at the Abdominal Lymph Nodes or Postoperative Stump including Pancreatic Stump and Other Stump Tianjin's Clinical Research Center for Cancer and Key Laboratory of Cancer Preven , 2022 .

[5]  Masakazu Yamamoto,et al.  Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers , 2015, World Journal of Surgery.

[6]  J. Mancias,et al.  Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer , 2015, Journal of Cancer.

[7]  J. Cameron,et al.  The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience , 2015, Annals of Surgical Oncology.

[8]  Albert C. Koong,et al.  Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma , 2014, Cancer.

[9]  T. Chiba,et al.  Comparative Outcomes Between Initially Unresectable and Recurrent Cases of Advanced Pancreatic Cancer Following Palliative Chemotherapy , 2014, Pancreas.

[10]  M. Yoshimura,et al.  Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer , 2014, Strahlentherapie und Onkologie.

[11]  D. Jäger,et al.  Improvement of surgical results for pancreatic cancer. , 2013, The Lancet. Oncology.

[12]  T. Pawlik,et al.  Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. , 2013, Journal of gastrointestinal oncology.

[13]  D. Jäger,et al.  Re-resection for Isolated Local Recurrence of Pancreatic Cancer is Feasible, Safe, and Associated with Encouraging Survival , 2013, Annals of Surgical Oncology.

[14]  P. Schirmacher,et al.  Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection , 2013, Radiation oncology.

[15]  N. Nasr,et al.  Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas , 2012, Radiation oncology.

[16]  T. Pawlik,et al.  Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation. , 2012, Practical radiation oncology.

[17]  N. Habib,et al.  Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy , 2012, Journal of Cancer Research and Clinical Oncology.

[18]  A. Koong,et al.  Cost‐effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer , 2012, Cancer.

[19]  N. Neerchal,et al.  Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients , 2010, Journal of Gastrointestinal Surgery.

[20]  Y. Nishimura,et al.  Postoperative external beam radiotherapy for resected pancreatic adenocarcinoma: impact of chemotherapy on local control and survival. , 2010, Anticancer research.

[21]  Mi-Sook Kim,et al.  Stereotactic body radiation therapy boost in locally advanced pancreatic cancer. , 2009, International journal of radiation oncology, biology, physics.

[22]  B. Topal,et al.  Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  Alison P. Klein,et al.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Choti,et al.  Determining Pattern of Recurrence Following Pancreaticoduodenectomy and Adjuvant 5-Flurouracil-Based Chemoradiation Therapy: Effect of Number of Metastatic Lymph Nodes and Lymph Node Ratio , 2009, Journal of Gastrointestinal Surgery.

[25]  Daniel T Chang,et al.  Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas , 2009, Cancer.

[26]  Zoran Bursac,et al.  Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.

[27]  T. Desser,et al.  Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. , 2008, International journal of radiation oncology, biology, physics.

[28]  H. Friess,et al.  Surgery for Recurrent Pancreatic Ductal Adenocarcinoma , 2007, Annals of surgery.

[29]  Quynh-Thu Le,et al.  Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. , 2005, International journal of radiation oncology, biology, physics.

[30]  E. Dühmke,et al.  Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. , 2005, JOP : Journal of the pancreas.

[31]  Albert C Koong,et al.  Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.

[32]  P. V. Rao,et al.  Applied Survival Analysis: Regression Modeling of Time to Event Data , 2000 .

[33]  R H Hruban,et al.  Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. , 1997, Annals of surgery.

[34]  A. Piccoli,et al.  Recurrence after resection for ductal adenocarcinoma of the pancreas , 1997, World Journal of Surgery.

[35]  S. Goodman,et al.  Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients , 1995, Annals of surgery.

[36]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[37]  M. Ohmuraya,et al.  Pancreatic cancer in the remnant pancreas following primary pancreatic resection , 2013, Surgery Today.

[38]  T. Eberlein.  Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial , 2008 .